Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis

Rapid Improvement After Starting Elexacaftor-tezacaftor-ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

(2021) Pierre-Régis Burgel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study

(2021) Ruth Marian Mitchell et al.   THORAX

Ethical dilemma: ELX/TEZ/IVA or Lung Transplantation in Cystic Fibrosis and End Stage Lung Disease?

(2021) Oded Breuer et al.   CHEST

Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation

(2021) Lorriana E. Leard et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France

(2021) Clémence Martin et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Re-Imagining Cystic Fibrosis Care: Next Generation Thinking

(2020) Catherine Rang et al.   EUROPEAN RESPIRATORY JOURNAL

Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease

(2020) Siddhartha G. Kapnadak et al.   Journal of Cystic Fibrosis

Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines

(2019) Kathleen J. Ramos et al.   Journal of Cystic Fibrosis

The future of cystic fibrosis care: a global perspective

(2019) Scott C Bell et al.   Lancet Respiratory Medicine

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

(2019) Harry G M Heijerman et al.   LANCET

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

(2019) Peter G. Middleton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

(2017) Jennifer L. Taylor-Cousar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Morphometric Analysis of Explant Lungs in Cystic Fibrosis

(2016) Mieke Boon et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Long-term computed tomographic changes in cystic fibrosis patients treated with ivacaftor

(2016) Guillaume Chassagnon et al.   EUROPEAN RESPIRATORY JOURNAL

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

(2015) Claire E. Wainwright et al.   NEW ENGLAND JOURNAL OF MEDICINE

Survival Benefit of Lung Transplant for Cystic Fibrosis since Lung Allocation Score Implementation

(2013) Gabriel Thabut et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation

(2011) Bonnie W. Ramsey et al.   NEW ENGLAND JOURNAL OF MEDICINE